Addressing Methamphetamine Abuse at the Pharmacy Counter

This activity is supported by an educational grant from Acura Pharmaceuticals Inc.

Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD

Drug Information Specialist Barnabas Health South Plainfield, New Jersey

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Shilpa Amara, PharmD

Pharmacy Times Office of Continuing Professional Education Planning Staff Judy V. Lum, MPA, and Steve Lin, PharmD

Pharmacy Times Editorial Staff

Kirk McKay and David Allikas

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

Upon completion of the educational activity, the participant should be able to:

• Discuss the origins of methamphetamine abuse and its health and economic toll.
• Examine the current status of methamphetamine abuse following implementation of legal restrictions on purchasing of implicated OTC drugs.
• Identify further efforts taken to minimize use of OTC drugs for manufacture of methamphetamine.
• Identify pharmacy implications associated with use of OTC products in methamphetamine production.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: September 13, 2013

Expiration date: September 13, 2015

Estimated time to complete activity: 2 hours

Fee: Free

Click here to view this activity.